12
Abdel Majid A. Adam / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 104 (2013) 1–13
plex exhibited moderate inhibitory results against all of the
Gram-positive and Gram-negative bacterial species, as reported
in Table 9.
Antifungal activity studies
The 4AAP and its synthesized CT complexes were also screened
for their antifungal properties against two fungal species, A. flavus
and C. albicans. Amphotericin B was used as a positive control, and
the screening data are reported in Table 9 and statistically pre-
sented in Fig. 12. The data revealed that the [(4AAP)(QL)] complex
had a significant antifungal response against C. albicans. The
[(4AAP)(PA)] complex exhibited no inhibitory activity against
either fungal species, as shown in Table 9. It is obvious that the
antimicrobial activities of the 4AAP CT complexes are more than
that of free 4AAP. The [(4AAP)(QL)] complex shows good antifungal
activities, while the free 4AAP has no such activity which makes
this complex of interest. The most reasons for lethal action of
tested 4AAP CT complexes may be due to their interactions with
critical intracellular sites causing the death of cells. The variety
of antimicrobial activities of tested 4AAP CT complexes may due
to a different degree of tested complexes penetration through cell
membrane structure of target organism [57].
B. subtilis
E. coli
P. aeuroginosa
S. aureus
Fig. 11. Statistical representation for antibacterial activity of 4AAP and its
complexes.
Conclusion
Structural studies of the newly synthesized charge-transfer
complexes of 4-aminoantipyrine (4AAP) with quinol (QL) and pic-
ric acid (PA) were carried out. Two new proton-transfer salts,
named 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-
aminium-4-hydroxyphenolate and 1,5-dimethyl-3-oxo-2-phenyl-
2,3-dihydro-1H-pyrazol-4-aminium-2,4,6-trinitrophenolate for QL
and PA, respectively, are formed via a 1:1 donor/acceptor stoichi-
ometry. The IR, Raman and 1H NMR spectra show that the com-
plexes formed between 4AAP and QL or PA are stabilized by
hydrogen bonding, which is formed between the phenolic group
of the acceptors and the primary amine of 4AAP. The obtained
complexes are nanoscale, semi-crystalline particles, and the com-
pound formed with PA is thermally stable up to 180 °C with a
remarkable sponge-like morphology. The antibacterial and anti-
fungal activities of the newly synthesized CT complexes were stud-
ied using the disc diffusion method, and [(4AAP)(QL)] exhibited
good microbial activities against various bacterial and fungal
strains compared with standard drugs.
Aspergillus flavus
Candida albicans
Fig. 12. Statistical representation for antifungal activity of 4AAP and its complexes.
In addition, the chemical compositions of the complexes were
determined using energy-dispersive X-ray diffraction (EDX). The
chemical analysis results from the EDX analysis for the formed
complexes showed a homogeneous distribution of each acceptor.
In the EDX profile, the peaks refer to all elements that constitute
the molecules of these complexes; these elements were clearly
identified, and the results confirmed the proposed structures.
References
Pharmacology
[1] Y.M. Chen, Y.P. Chen, Fluid Phase Equilibr. 282 (2009) 82.
[2] Y. Teng, F. Ji, C. Li, Z. Yu, R. Liu, J. Lumin. 131 (2011) 2661.
[3] Y. Teng, R. Liu, C. Li, H. Zhang, J. Hazard. Mater. 192 (2011) 1766.
[4] A. Lang, C. Hatscher, C. Wiegert, P. Kuhl, Amino Acids 36 (2009) 333.
[5] V. Mishra, R. Kumar, Carbohydr. Polym. 86 (2011) 296.
[6] A. Lang, C. Hatscher, P. Kuhl, Tetra. Lett. 48 (2007) 3371.
[7] S. Cunha, S.M. Oliveira, M.T. Rodriques, R.M. Bastos, J. Ferrari, C.M.A. de
Oliveira, L. Kato, H.B. Napolitano, I. Vencato, C. Lariucci, J. Mol. Struct. 752
(2005) 32.
The 4AAP and its CT complexes were screened in vitro for their
antibacterial and antifungal activity. The CT complexes to be tested
were dissolved in DMSO to obtain 100 lg/ml stock solutions. The
diameter zones were measured to determine their effects on the
growth of the tested microorganisms.
[8] S. Prasad, R.K. Agarwal, Transit. Metal Chem. 32 (2007) 143.
[9] J.F. Van Staden, N.W. Beyene, R.I. Stefan, H.Y. Aboul-Enein, Talanta 68 (2005)
401.
Antibacterial activity studies
[10] J. Kasthuri, J. Santhanalakshmi, N. Rajendiran, Transit. Metal Chem. 33 (2008)
899.
[11] C.Z. Katsaounos, E.K. Paleologos, D.L. Giokas, M.I. Karayannis, Int. J. Environ.
Anal. Chem. 83 (2003) 507–514.
[12] A.M. Farghaly, A. Hozza, Pharmazie 35 (1980) 596.
[13] D. Chiaramonte, J.M. Steiner, J.D. Broussard, K. Baer, S. Gumminger, E.M.
Moller, D.A. Williams, R. Shumway, Can. J. Vet. Res. 67 (2003) 183.
[14] P.M. Selvakumar, E. Suresh, P.S. Subramanian, Polyhedron 26 (2007) 749.
[15] N.L. Olenovich, L.I. Koval Chuk, Zh. Anal. Khim 28 (1975) 2162.
[16] Y. Teng, R. Liu, C. Li, Q. Xia, P. Zhang, J. Hazard. Mater. 190 (2011) 574.
[17] A.M. Vinagre, E.F. Collares, Braz. J. Med. Biol. Res. 40 (2007) 903.
[18] S.G. Sunderji, A. El Badry, E.R. Poore, J.P. Figueroa, P.W. Nathanielsz, Am. J.
Obstet. Gynecol. 149 (1984) 408.
The antibacterial activity of the 4AAP and its complexes were
tested in vitro against two Gram-positive bacterial strains, S. aureus
(S. aureus) and B. subtilis, and two Gram-negative bacterial strains,
E. coli (E. coli) and P. aeruginosa (P. aeruginosa). The activity was
determined by measuring the inhibition zone diameter values
(mm) of the complexes against the microorganisms. Tetracycline
was used as a positive control. The screening data are given in Ta-
ble 9 and are statistically presented in Fig. 11. The data reveal that
the [(4AAP)(QL)] complex showed good inhibitory activity against
the growth of the tested bacterial strains. The [(4AAP)(PA)] com-